Pfizer Nears $7.3bn Deal to Acquire Obesity Drug Developer Metsera
Pharmaceutical company Pfizer is close to finalizing a $7.3bn takeover of Metsera, a biotech company developing next-generation obesity treatments, in
Emmanuel Eze
September 22, 2025
